Annovis Bio, Inc.
ANVS
$2.60
-$0.10-3.70%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.79% | 2.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.71% | 53.50% | |||
| Operating Income | 6.71% | -53.50% | |||
| Income Before Tax | 5.59% | 53.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.59% | 53.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.59% | 53.60% | |||
| EBIT | 6.71% | -53.50% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 25.26% | 56.36% | |||
| Normalized Basic EPS | 25.29% | 56.35% | |||
| EPS Diluted | 33.03% | 50.94% | |||
| Normalized Diluted EPS | 25.29% | 56.35% | |||
| Average Basic Shares Outstanding | 26.36% | 6.31% | |||
| Average Diluted Shares Outstanding | 26.36% | 6.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||